Piracetam (Epilepsy = All indications)

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Congenital heart defects142.78 [2.54, 8018.04]-1 study41not evaluable ROB285.05 [4.52; .]
Digestive system anomalies183.86 [3.18, 10641.11]-1 study31not evaluable ROB367.21 [5.81; .]
Hypospadias98.54 [1.81, 5355.46]-1 study61not evaluable ROB196.58 [3.03; .]
Limb defects257.80 [4.22, 15744.39]-1 study21not evaluable ROB515.10 [7.91; .]
Neural Tube Defects430.33 [6.23, 29713.20]-1 study11not evaluable ROB860.17 [11.94; .]
Oro-facial clefts430.33 [6.23, 29713.20]-1 study11not evaluable ROB860.17 [11.94; .]
2 non statistically significant endpoints reported in only one study